Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| The Top 35 Central Nervous System Drug Delivery Technology Companies Worldwide | May 2009 | £235 | 100% |
| Drug Delivery to CNS Technologies, Markets and Companies |
Jan 2012 | £1,945 | 94% |
| Drug Delivery Systems US industry forecasts for 2015 & 2020 |
Jan 2012 | £3,035 | 93% |
| Pain Therapeutics Technologies, Markets and Companies |
Jan 2012 | £2,590 | 87% |
| Oral Drug Delivery Market Controlled and Sustained Release to be Major Revenue Generators |
Nov 2010 | £2,215 | 87% |
| Drug Delivery Technology: Revolutionizing CNS Therapies | Dec 2007 | £945 | 85% |
| Strategic Analysis of the European Specialty Pharma Market | Mar 2009 | £4,110 | 85% |
| Advanced Drug Delivery Systems New Developments, New Technologies |
Aug 2009 | £3,065 | 85% |
| Pharmaceutical Licensing Overview | Mar 2010 | £9,615 | 83% |
| Drug Delivery Systems US Market Outlook, Advances for Pharma, Biotech & Medical Devices |
Sep 2006 | £1,450 | 78% |
| Medical Imaging Reagents and Analysis Equipment | Jan 2010 | £3,065 | 76% |
| Biotechnology | Sep 2008 | £915 | 75% |
| Cell therapy (2 parts) Technologies, Markets and Companies |
Jan 2012 | £3,560 | 75% |
| Markets for Emerging Pharmaceutical Technologies | Mar 2011 | £3,065 | 74% |
| Pipeline Insight: Epilepsy Past successes hard to emulate in highly genericized market |
May 2010 | £7,210 | 74% |
| Biobanking: Technologies and Global Markets | Jun 2011 | £3,065 | 72% |
| Cell Therapy Markets | Jul 2007 | £2,150 | 71% |
| Advanced Drug Delivery Systems: Probing the Route to Growth New Developments, New Technologies, Companies and Trends |
Oct 2005 | £1,230 | 71% |
| Stem Cells Market Trends 2010 Drug Discovery/Toxicity Screening and Regenerative Medicine |
Apr 2010 | £1,015 | 70% |
| Stakeholder Opinions: Parkinson\'s Disease Review of Key Commercial Opportunities in the Symptomatic Treatment Market |
Jul 2006 | £1,335 | 70% |
| Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015 |
Jan 2011 | £995 | 69% |
| Antiageing and Life Enhancement Pharmacotherapeutics | Jan 2006 | £795 | 69% |
| Drug Delivery Partnering Terms and Agreements in Pharma and Biotech 2nd Edition |
Nov 2010 | £1,705 | 69% |
| Clinical Trials Business; The | Jan 2006 | £2,760 | 68% |
| Neuroprotection (2 parts) Technologies, Markets and Companies |
Jan 2012 | £3,240 | 68% |
| Advances in Peptide Therapeutics | Sep 2010 | £4,110 | 67% |
| Stakeholder Opinions: Therapeutic Vaccines A far-off promise of greatness |
Dec 2009 | £2,405 | 66% |
| Controlled-release: Players, products & prospects to 2018 (Volume I) | Jun 2009 | £595 | 65% |
| Nanotechnology in Health Care US Industry Study with Forecasts to 2011, 2016 & 2021 |
Feb 2007 | £2,845 | 62% |
| Parkinson's Disease Market analysis and forecasts 2008-2012, 2017 & 2022 |
Jan 2008 | £1,499 | 62% |
